Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing, Fengming Yang, Chuchu Shao, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1567

Showing 1-25 of 1567 citing articles:

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao, Yunxiang Zhou, Lihong Liu, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 1024
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Shreelaxmi Gavas, Sameer Quazi, Tomasz M. Karpiński
Nanoscale Research Letters (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 668
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng, Tong Meng, Lei Chen, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 535
DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy
Ruixue Huang, Ping‐Kun Zhou
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 515
The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
Asieh Emami Nejad, Simin Najafgholian, Alireza Rostami, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 507
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wei Wu, Jessica Klockow, Michael Zhang, et al.
Pharmacological Research (2021) Vol. 171, pp. 105780-105780
Open Access | Times Cited: 454
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Agnese Gagliardi, Elena Giuliano, Eeda Venkateswararao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 405
EMT, cancer stem cells and autophagy; The three main axes of metastasis
Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Nasrin Zare Zavieyh Jaghi
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110909-110909
Open Access | Times Cited: 403
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang, Ziyu Dai, Wantao Wu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 353
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 308
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Bárbara Pinto, Ana C. Henriques, Patrícia Silva, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1186-1186
Open Access | Times Cited: 304
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
Qing Li, Yong Ni, Liren Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 282
Oral squamous cell carcinomas: state of the field and emerging directions
Yunhan Tan, Zhihan Wang, Mengtong Xu, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 259
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle, Vladimir Dobričić, Loretta Lazzarato, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100682-100682
Open Access | Times Cited: 241
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 223
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Bin Wang, Qin Zhao, Yuyu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 221
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 196
A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities
Miguel Á. Ortega, Oscar Fraile‐Martínez, Cielo García‐Montero, et al.
Medicina (2021) Vol. 57, Iss. 9, pp. 864-864
Open Access | Times Cited: 180
A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability
Peng‐Peng Zhu, Fang He, Yixuan Hou, et al.
Oncogene (2021) Vol. 40, Iss. 9, pp. 1609-1627
Open Access | Times Cited: 178
Obesity, Diabetes, and Increased Cancer Progression
Dae-Seok Kim, Philipp E. Scherer
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 6, pp. 799-812
Open Access | Times Cited: 165
The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
Ruixue Bai, Yunong Li, Lingyan Jian, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2
Dongliang Wang, Chaoshuai Zhao, Fei Xu, et al.
Theranostics (2021) Vol. 11, Iss. 6, pp. 2860-2875
Open Access | Times Cited: 159
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 156
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
Wanzun Lin, Shihong Wu, Xiaochuan Chen, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 153
The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC)
Debasish Basak, Mohammad N. Uddin, Jake Hancock
Cancers (2020) Vol. 12, Iss. 11, pp. 3336-3336
Open Access | Times Cited: 152
Page 1 - Next Page

Scroll to top